IGHE and neoplasm: Mediators of the Th2 pathway also may divert tissue immunity away from an anti-tumor Th1 response (i.e., IgG1, TNF-α) and toward an IgE response against allergens, and not tumor antigens through “inappropriate Th2 immune skewing” (100).